drugset / Trial / NCT00525590

Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer

NCT00525590

Phase 2 Completed 69 enrolled Eisai Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effect of the surgical intervention and insertion of GLIADEL wafers on the neurocognitive functioning in patients with metastatic brain cancer.

Timeline

Start
2007-12-12
Primary completion
2010-12-01
Completion
2010-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject carmustine Small molecule 61.6 mg Other